PATTERN OF HEPATIC ENZYMES PROFILE IN SICKLE CELL DISEASE PATIENTS ATTENDING MADONNA UNIVERSITY TEACHING HOSPITAL (MUTH)
NNODIM JOHNKENNEDY *
Department of Medical Laboratory Science, Imo State University, Owerri, Nigeria.
NWOKEJI CHIBUDO ODERA
Department of Medical Laboratory Science, Madonna University, Elele Rivers, Nigeria.
NWOKEJI CALISTUS MUODEBE
Department of Medical Laboratory Science, Madonna University, Elele Rivers, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Sickle cell anaemia is a lifelong blood disorder characterized by red blood cells that assume an abnormal, rigid, sickle shape. The sickling occurs because of a mutation in the haemoglobin gene. This study, is aimed at evaluating liver enzymes in Sickle cell anaemia. Before the commencement of the study, ethical approval was obtained from the Madonna University teaching hospital Ethical Committee. The study consists of 233 subjects divided into two (2) groups. Ninety (90) subjects with Hemoglobin Genotype HbAA and one Hundred and fourty three (143) subjects with the Genotype HbSS. Cellulose acetate alkaline hemoglobin electrophoresis technique was used in determination of hemoglobin genotype. Reitman-frankel method was used in in-vitro determination of ALT and AST activities. Phenolphthalein Monophosphate method was used in in-vitro determination of ALP activity. The data obtained was analysed using Statistical Package of Social Sciences (SPSS) Version 26. There was a significant difference in AST levels (IU/l) of HbAA (22.46±2.51) when compared to HbSS (72.03±25.94), t(126) = 10.07, p. value = 0.000. There was also a significant difference in ALP levels (IU/l) of HbAA (19.54±3.34) when compared to HbSS(70.25±17.65), t(126) = 15.09, p. value = 0.000. A significant difference, was also observed in ALT levels (IU/l) of HbAA(16.53±2.51) when compared to HbSS(64.50±27.17) t(103) = 17.44, p. value = 0.000. Patients with sickle cell disease can develop liver disease as a result of intrahepatic sickling of erythrocytes, viral hepatitis and iron overload secondary to multiple blood transfusions, and gallstone disease as a result of chronic hemolysis.
Keywords: Pattern, hepatic enzymes, sickle cell disease, patients, Madonna University Teaching Hospital
How to Cite
Downloads
References
Onimoe G, Rotz S. Sickle cell disease: A primary care update. Cleve Clin J Med. 2020; 87(1):19-27.
Williams TN, Thein SL. Sickle cell anemia and its phenotypes. Annu Rev Genomics Hum Genet. 2018;19:113-47.
Demirci S, Uchida N, Tisdale JF. Gene therapy for sickle cell disease: an update. Cytotherapy. 2018;20(7):899-910.
Mandal AK, Mitra A, Das R. Sickle cell hemoglobin. Subcell Biochem. 2020;94:297-322
Pinto VM, Balocco M, Quintino S, Forni GL. Sickle cell disease: A review for the internist. Intern Emerg Med. 2019;14(7):1051-64.
Risinger M, Kalfa TA. Red cell membrane disorders: structure meets function. Blood. 2020;136(11):1250-61.
Capelli R, Kitano Y, Linhares M, Da Silva D, Golse N, Karam V et al. The prognostic significance of serum aspartate transaminase and gamma-glutamyl transferase in liver deceased donors. Transpl Int. 2021;34(11): 2247-56.
Green MR, Sambrook J. Alkaline phosphatase. Cold Spring Harb Protoc. 2020; 2020(8):100768.
Airaodion AI, Ogbuagu EO, Ogbuagu U, Adeniji AR, Agunbiade AP, Airaodion EO. Hepatoprotective effect of Parkia biglobosa on acute ethanol-induced oxidative stress in Wistar rats. Int Res J Gastroenterol Hepatol. 2019;2(1):1-11.
Uche CL, Isaiah AO, Ezirim EO, Airaodion AI. Sickle cell anemia contributes to liver abnormality. Int J Res Rep Hematol. 2022;5(2):122-34.
Obi CU, Aladeyelu OS, Agbiogwu IN, Agu CN, Arusiwon JA, Udeh MO. Enzyme activities of liver function (biomarkers) in sickle cell anaemic patients attending sickle cell anaemic Centre, Benin City, Edo State, Nigeria. Int J Blood Res Disord. 2020;7(2): 1-5.
Kotila T, Adedapo K, Adedapo A, Oluwasola O, Fakunle E, Brown B. Liver dysfunction in steady state sickle cell disease. Ann Hepatol. 2005;4(4):261-3. 16432491